23andMe Directors Resign
23andMe Board Quits As CEO Of DNA Testing Company Plans To Go Private
The board of directors for 23andMe quit following disagreements over the CEO's plans to privatize the DNA testing company.
23andMe directors resign as the CEO of the genetic-testing company seeks to take it private
All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the genetic-testing company.
23andMe Board Resigns in New Blow to DNA-Testing Company
All seven independent directors of DNA-testing company 23andMe resigned, following a protracted negotiation with CEO Anne Wojcicki over her plan to take the company private.
Independent Directors of 23andMe Resign from Board
The independent directors of the Board of 23andMe Holding Co. (Nasdaq: ME), today sent the following letter to Anne Wojcicki, Chief Executive Officer, Co-Founder, and Chair of the Board of Directors of 23andMe,
23andMe independent directors quit board over unsatisfactory buyout plan from CEO
The independent directors of genetic testing firm 23andMe said on Tuesday they have resigned from the company's board after not receiving a satisfactory take-private offer from CEO Anne Wojcicki.
23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private
All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.
23andMe board quits over plans to take DNA testing company private
All seven independent directors of 23andMe’s board resigned on Tuesday, citing disagreements over the chief executive’s plan to take the company private. The departures leave just one
Directors Resign as 23andMe Privatization Efforts Sputter
Board memebers quit as founder Anne Wojcicki works to come up with an acceptable financial offer to purchase its remaining shares and take the company private.
ME INVESTOR NEWS: If You are a Current Shareholder of 23andMe Holding Co., Contact BFA Law about its Investigation into the Board of Directors
If you are a holder of 23andMe, you are encouraged to submit your information at: On July 29, 2024, CEO Wojcicki submitted a non-binding proposal to 23andMe to acquire all shares of 23andMe that were ...
Rolling Out2d
23andMe’s board resignation: Money problems and ties to the Black community
On Sept. 23, the board of directors at 23andMe, a prominent DNA testing company, announced their resignation following a series of disagreements with CEO Ann ...
23andMe sees independent board directors quit en masse
Me, the personal genomics company, went public in early 2021 via a merger with a blank check company that valued it at $3.5 ...
Read the memo 23andMe's cofounder sent to staff after the entire board quit
Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.
BioPharma Dive6d
23andMe’s independent board directors resign
In a letter to CEO Anne Wojcicki, the directors said they’d resign “rather than have a protracted and distracting difference of view with you” about the company’s future.